OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - US6907321029 - Common Stock
4.9 USD
-0.06 (-1.21%)
4.9 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to OMI. OMI was compared to 101 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. OMI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OMI had positive earnings in the past year.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
Each year in the past 5 years OMI had a positive operating cash flow.
1.2 Ratios
OMI has a worse Return On Assets (-28.95%) than 86.14% of its industry peers.
OMI's Return On Invested Capital of 13.26% is amongst the best of the industry. OMI outperforms 90.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is below the industry average of 9.14%.
The 3 year average ROIC (6.37%) for OMI is below the current ROIC(13.26%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.95% | ||
| ROE | N/A | ||
| ROIC | 13.26% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
1.3 Margins
OMI has a Operating Margin (2.85%) which is comparable to the rest of the industry.
OMI's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 22.79%, OMI perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
OMI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 22.79% |
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
OMI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
The number of shares outstanding for OMI has been increased compared to 5 years ago.
Compared to 1 year ago, OMI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.95 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
OMI has a Altman-Z score of 1.95. This is comparable to the rest of the industry: OMI outperforms 45.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.95 |
ROIC/WACC1.82
WACC7.28%
2.3 Liquidity
A Current Ratio of 0.86 indicates that OMI may have some problems paying its short term obligations.
With a Current ratio value of 0.86, OMI is not doing good in the industry: 78.22% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that OMI may have some problems paying its short term obligations.
OMI's Quick ratio of 0.83 is on the low side compared to the rest of the industry. OMI is outperformed by 74.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
OMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.10%.
The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
The Revenue for OMI has decreased by -17.10% in the past year. This is quite bad
The Revenue has been growing slightly by 3.04% on average over the past years.
EPS 1Y (TTM)-13.1%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-27.78%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.47%
3.2 Future
OMI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.95% yearly.
OMI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -26.35% yearly.
EPS Next Y-32.85%
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
EPS Next 5Y2.95%
Revenue Next Year-70.33%
Revenue Next 2Y-49.09%
Revenue Next 3Y-35.45%
Revenue Next 5Y-26.35%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 3.36, which indicates a rather cheap valuation of OMI.
OMI's Price/Earnings ratio is rather cheap when compared to the industry. OMI is cheaper than 100.00% of the companies in the same industry.
OMI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.08.
The Price/Forward Earnings ratio is 4.90, which indicates a rather cheap valuation of OMI.
Based on the Price/Forward Earnings ratio, OMI is valued cheaply inside the industry as 99.01% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.72. OMI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.36 | ||
| Fwd PE | 4.9 |
4.2 Price Multiples
94.06% of the companies in the same industry are more expensive than OMI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.68 |
4.3 Compensation for Growth
A cheap valuation may be justified as OMI's earnings are expected to decrease with -8.32% in the coming years.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
5. Dividend
5.1 Amount
OMI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.9
-0.06 (-1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.24%
Inst Owner Change-0.36%
Ins Owners3.64%
Ins Owner Change19.58%
Market Cap378.48M
Analysts48.33
Price Target6.26 (27.76%)
Short Float %9.37%
Short Ratio4.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.19%
Min EPS beat(2)-6.28%
Max EPS beat(2)16.66%
EPS beat(4)3
Avg EPS beat(4)3.96%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)6.12%
EPS beat(12)10
Avg EPS beat(12)14.68%
EPS beat(16)13
Avg EPS beat(16)14.84%
Revenue beat(2)0
Avg Revenue beat(2)-38.63%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-1.97%
Revenue beat(4)1
Avg Revenue beat(4)-19.33%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-10.02%
Revenue beat(12)5
Avg Revenue beat(12)-5.72%
Revenue beat(16)8
Avg Revenue beat(16)-4.2%
PT rev (1m)-38.6%
PT rev (3m)-41.63%
EPS NQ rev (1m)-47.88%
EPS NQ rev (3m)-54.81%
EPS NY rev (1m)-39.04%
EPS NY rev (3m)-40.07%
Revenue NQ rev (1m)-74.85%
Revenue NQ rev (3m)-74.63%
Revenue NY rev (1m)-71.13%
Revenue NY rev (3m)-71.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.36 | ||
| Fwd PE | 4.9 | ||
| P/S | 0.04 | ||
| P/FCF | N/A | ||
| P/OCF | 3.75 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.68 |
EPS(TTM)1.46
EY29.8%
EPS(NY)1
Fwd EY20.41%
FCF(TTM)-2.15
FCFYN/A
OCF(TTM)1.31
OCFY26.65%
SpS113.04
BVpS-3.64
TBVpS-22.06
PEG (NY)N/A
PEG (5Y)0.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.95% | ||
| ROE | N/A | ||
| ROCE | 16.79% | ||
| ROIC | 13.26% | ||
| ROICexc | 13.61% | ||
| ROICexgc | 1049.61% | ||
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 22.79% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexcg growth 3Y-4.88%
ROICexcg growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score4
Asset Turnover2.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.22 | ||
| Cap/Depr | 108.01% | ||
| Cap/Sales | 3.06% | ||
| Interest Coverage | 1.82 | ||
| Cash Conversion | 20.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 1.95 |
F-Score4
WACC7.28%
ROIC/WACC1.82
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.1%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-27.78%
EPS Next Y-32.85%
EPS Next 2Y-18.88%
EPS Next 3Y-8.32%
EPS Next 5Y2.95%
Revenue 1Y (TTM)-17.1%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.47%
Revenue Next Year-70.33%
Revenue Next 2Y-49.09%
Revenue Next 3Y-35.45%
Revenue Next 5Y-26.35%
EBIT growth 1Y-19.73%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year85.47%
EBIT Next 3Y28.56%
EBIT Next 5YN/A
FCF growth 1Y-139.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.91%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%